Respiratory system Flashcards
(Antihistamine, H1-receptor antagonists)
Blocks histamine binding at the H1-receptor. histamine is released in response to antigen binding to IgE on surfaces of mast cells.
Cetirizine
(Antihistamine, H1-receptor antagonists)
Allergies (i.e. hay fever)
Itchiness and hives
Adjunctive treatment for anaphylaxis alongside adrenaline
Loratadine
(Antihistamine, H1-receptor antagonists)
Allergies (i.e. hay fever)
Itchiness and hives
Adjunctive treatment for anaphylaxis alongside adrenaline
Fexofenadine
(Antihistamine, H1-receptor antagonists)
Allergies (i.e. hay fever)
Itchiness and hives
Adjunctive treatment for anaphylaxis alongside adrenaline
Chlorophenamine
(Antihistamine, H1-receptor antagonists)
Allergies (i.e. hay fever)
Itchiness and hives
Adjunctive treatment for anaphylaxis alongside adrenaline
(Antimuscarinics, bronchodilators)
Antimuscarinic bind to muscarinic receptor, otherwise bound by acetylcholine. Muscarininc receptors mediate parasympathetic effects. Antimuscarinincs therefore exert sympathetic effect (i.e. reduce smooth muscle tone, reduce glandular secretion)
Ipratropium
(Antimuscarinics, bronchodilators)
Chronic obstructive pulmonary disease
Asthma
Tiotropium
(Antimuscarinics, bronchodilators)
Chronic obstructive pulmonary disease
Asthma
Glycopyrronium
(Antimuscarinics, bronchodilators)
Chronic obstructive pulmonary disease
Asthma
Aclidinium
(Antimuscarinics, bronchodilators)
Chronic obstructive pulmonary disease
Asthma
(Beta-2-agonist)
Beta-2 receotors present in smooth muscle of bronchi, gut, uterus and blood vessels. Stimulation of these G-protein coupled receptors activate signalling cascade leading to smooth muscle relaxation. Also like insulin, beta-2-agonists stimulate Na+/K+ATPase pumps on cell surface and shifting K+ ions into cells. Useful in treating hyperkalaemia. Classified as short acting and long acting
Salbutamol
(Short acting Beta-2-agonist)
Asthma
COPD
Hyperkalaemia
Terbutaline
(Short acting Beta-2-agonist)
Asthma
COPD
Sameterol
(Long acting Beta-2-agonist)
Asthma
COPD
Formoterol
(Long acting Beta-2-agonist)
Asthma
COPD
Indacaterol
(Beta-2-agonist)
Asthma
COPD
(Corticosteroid, glucocorticoids, inhaled)
Corticosteroids pass through plasma membrane ultimately modifying transcription of several genes. Leads to down-regulation of pro-inflammatroy interleukins, cytokines, chemokines. Whilst up-regulating anti-inflammtory proteins. Widens airways in asthma and COPD
Beclometasone
(Corticosteroid, glucocorticoids, inhaled)
Asthma
COPD
Budesonide
(Corticosteroid, glucocorticoids, inhaled)
Asthma
COPD
Fluticasone
(Corticosteroid, glucocorticoids, inhaled)
Asthma
COPD
(Leukotriene receptor antagonist)
In asthma leukotriene produced by mast cells and eosinophils activates G-protein-couple leukotriene receptors CysLT1. This leads to inflammation and bronchoconstriciton. Antagonists block CysLT1, to downregulate inflammatory response
Monteluksat
(Leukotriene receptor antagonist)
Asthma (adult and children)
(Oxygen)
Oxygen supplementation increases alveolar PO2 to increase delivery of oxygen to hypoxic tissue. In pneumothorax, supplemental oxygen reduces fraction of nitrogen in alveolar gas. Pleural air mostly made of nitrogen, so supplemental oxygen increases re-uptake of nitrogen and out of body. In CO poisoning, oxygen competes with CO in binding to haemoglobin. O2 therapy shortens half life of carboxyhemoglobin.
Acute hypoxaemia
Pneumothorax
Carbon monoxide poisoning